{
    "label": "Age of patient?",
    "node_type": "fieldset",
    "children": [
        {
            "label": "For adults (age 18 years and older)",
            "outcome": "Authorization for Wegovy™ (semaglutide), may be approved when all of the criteria are met",
            "node_type": "radio",
            "node_value": false,
            "children": [
                {
                    "label": "Is this request for initiation or continuation of therapy with Wegovy™ (semaglutide)?",
                    "node_type": "fieldset",
                    "children": [
                        {
                            "label": "Start of therapy",
                            "outcome": "Initial Authorization for Wegovy™ (semaglutide) may be granted for 4 months when the criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "children": [
                                {
                                    "label": "Member is ≥ 18 years old",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Member’s body mass index (BMI) meets either requirement:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "A body mass index (BMI) greater than or equal to 30 kg/m^2",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Meets body mass index (BMI) and comorbidity requirements:",
                                            "all_required": true,
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "children": [
                
                                                {
                                                    "label": "An initial body mass index (BMI) of greater than or equal to 27 kg/m^2",
                                                    "node_type": "checkbox",
                                                    "node_value": false
                                                },
                                                {
                                                    "label": "The patient has at least one weight-related comorbid condition:",
                                                    "node_type": "checkbox",
                                                    "node_value": false,
                                                    "children": [
                                                        {
                                                            "label": "Established cardiovascular disease or stroke",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Hypertension",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Type 2 diabetes (DM)",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Chronic kidney disease (CKD)",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Congenital heart disease (CHD)",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Obstructive sleep apnea",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Polycystic ovarian syndrome",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Dyslipidemia",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Non-alcoholic fatty liver disease",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Idiopathic intracranial hypertension",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Osteoarthritis in weight-bearing joints",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        }
                                                    ]
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "label": "Member’s current weight must be submitted to the plan for review (within 30 days)",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Lifestyle Modification Program participation:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Provider can submit documentation of active participation in a covered BCBSM/BCN lifestyle modification program",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Documentation of active participation in an alternative concurrent lifestyle modification program (e.g., recent food diaries, exercise logs, program receipts, app participation, etc.) if the member does not have access to a covered BCBSM/BCN program",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                },
                                {
                                    "label": "Not to be used in combination with other weight loss products",
                                    "node_type": "checkbox",
                                    "node_value": false
                                }
                            ]
                        },
                        {
                            "label": "Continuation of therapy",
                            "outcome": "Reauthorization for Wegovy™ (semaglutide) may be granted when the criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "children": [
                                {
                                    "label": "Continued coverage will be reviewed annually",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "The member has maintained at least a 5% weight loss from baseline",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Requires documentation of continued participation in lifestyle modification program",
                                    "node_type": "checkbox",
                                    "node_value": false
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "label": "For adolescents (12 to 17 years of age)",
            "outcome": "Authorization for Wegovy™ (semaglutide), may be approved when all of the criteria are met",
            "node_type": "radio",
            "node_value": false,
            "children": [
                {
                    "label": "Is this request for initiation or continuation of therapy with Wegovy™ (semaglutide)?",
                    "node_type": "fieldset",
                    "children": [
                        {
                            "label": "Start of therapy",
                            "outcome": "Initial Authorization for Wegovy™ (semaglutide) may be granted for 4 months when the criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "children": [
                                {
                                    "label": "Member’s age is 12 to 17 years",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Member’s body mass index (BMI) is ≥ 95th percentile, standardized for age and sex",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Member’s current weight must be submitted to the plan for review (within 30 days)",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Lifestyle Modification Program participation:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Provider can submit documentation of active participation in a covered BCBSM/BCN lifestyle modification program",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Documentation of active participation in an alternative concurrent lifestyle modification program (e.g., recent food diaries, exercise logs, program receipts, app participation, etc.) if the member does not have access to a covered BCBSM/BCN program",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                },
                                {
                                    "label": "Not to be used in combination with other weight loss products",
                                    "node_type": "checkbox",
                                    "node_value": false
                                }
                            ]
                        },
                        {
                            "label": "Continuation of therapy",
                            "outcome": "Reauthorization for Wegovy™ (semaglutide) may be granted when the criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "children": [
                                {
                                    "label": "Continued coverage will be reviewed annually",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "The member has maintained at least a 1% reduction in BMI from baseline",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Requires documentation of continued participation in lifestyle modification program",
                                    "node_type": "checkbox",
                                    "node_value": false
                                }
                            ]
                        }
                    ]
                }
            ]
        }
    ]
}